515 related articles for article (PubMed ID: 15952056)
1. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
2. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
[TBL] [Abstract][Full Text] [Related]
3. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
4. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas.
Saussez S; Decaestecker C; Lorfevre F; Chevalier D; Mortuaire G; Kaltner H; André S; Toubeau G; Gabius HJ; Leroy X
Histopathology; 2008 Mar; 52(4):483-93. PubMed ID: 18315601
[TBL] [Abstract][Full Text] [Related]
5. Glycoprobes as a tool for the study of lectins expressed on tumor cells.
Kurmyshkina O; Rapoport E; Moiseeva E; Korchagina E; Ovchinnikova T; Pazynina G; Belyanchikov I; Bovin N
Acta Histochem; 2010 Mar; 112(2):118-26. PubMed ID: 19285339
[TBL] [Abstract][Full Text] [Related]
6. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer.
Irie A; Yamauchi A; Kontani K; Kihara M; Liu D; Shirato Y; Seki M; Nishi N; Nakamura T; Yokomise H; Hirashima M
Clin Cancer Res; 2005 Apr; 11(8):2962-8. PubMed ID: 15837748
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of galectin-3 is associated with progression of human breast cancer.
Castronovo V; Van Den Brûle FA; Jackers P; Clausse N; Liu FT; Gillet C; Sobel ME
J Pathol; 1996 May; 179(1):43-8. PubMed ID: 8691344
[TBL] [Abstract][Full Text] [Related]
8. Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model.
Stannard KA; Collins PM; Ito K; Sullivan EM; Scott SA; Gabutero E; Darren Grice I; Low P; Nilsson UJ; Leffler H; Blanchard H; Ralph SJ
Cancer Lett; 2010 Dec; 299(2):95-110. PubMed ID: 20826047
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients.
van den Brûle FA; Waltregny D; Castronovo V
J Pathol; 2001 Jan; 193(1):80-7. PubMed ID: 11169519
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.
Nagae M; Nishi N; Nakamura-Tsuruta S; Hirabayashi J; Wakatsuki S; Kato R
J Mol Biol; 2008 Jan; 375(1):119-35. PubMed ID: 18005988
[TBL] [Abstract][Full Text] [Related]
11. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
[TBL] [Abstract][Full Text] [Related]
12. Galectin-9, a novel prognostic factor with antimetastatic potential in breast cancer.
Yamauchi A; Kontani K; Kihara M; Nishi N; Yokomise H; Hirashima M
Breast J; 2006; 12(5 Suppl 2):S196-200. PubMed ID: 16959001
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells.
Ohannesian DW; Lotan D; Thomas P; Jessup JM; Fukuda M; Gabius HJ; Lotan R
Cancer Res; 1995 May; 55(10):2191-9. PubMed ID: 7743523
[TBL] [Abstract][Full Text] [Related]
14. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
[TBL] [Abstract][Full Text] [Related]
15. Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance.
Langbein S; Brade J; Badawi JK; Hatzinger M; Kaltner H; Lensch M; Specht K; André S; Brinck U; Alken P; Gabius HJ
Histopathology; 2007 Nov; 51(5):681-90. PubMed ID: 17927590
[TBL] [Abstract][Full Text] [Related]
16. Varied expression and localization of multiple galectins in different cancer cell lines.
Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
[TBL] [Abstract][Full Text] [Related]
17. Are matrix-immobilized neoglycoproteins, plant and human lectins and carbohydrate--binding antibodies from human serum mediators of adhesion in vitro for carcinoma and lymphosarcoma cells?
Wawotzny R; André S; Dong X; Joshi SS; Gabius HJ
Anticancer Res; 1995; 15(1):169-74. PubMed ID: 7733629
[TBL] [Abstract][Full Text] [Related]
18. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
[TBL] [Abstract][Full Text] [Related]
19. Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells.
Galiè M; Sorrentino C; Montani M; Micossi L; Di Carlo E; D'Antuono T; Calderan L; Marzola P; Benati D; Merigo F; Orlando F; Smorlesi A; Marchini C; Amici A; Sbarbati A
Carcinogenesis; 2005 Nov; 26(11):1868-78. PubMed ID: 15975963
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 expression in non-small cell lung carcinoma.
Puglisi F; Minisini AM; Barbone F; Intersimone D; Aprile G; Puppin C; Damante G; Paron I; Tell G; Piga A; Di Loreto C
Cancer Lett; 2004 Aug; 212(2):233-9. PubMed ID: 15279903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]